期刊文献+

男性肝纤维化患者雌激素水平变化的临床意义 被引量:1

Change of serum levels of estrogen and clinical significance in the male patients with fibrosis of liver
下载PDF
导出
摘要 目的探讨男性肝纤维化患者雌激素水平的变化以及与血清透明质酸(HA)、Ⅲ型前胶原肽(PⅢNP)、Ⅳ型胶原(Ⅳ-C)、层粘连蛋白(LN)及肝功损害的关系。方法采用酶联免疫法检测31例健康男性、26例男性慢性肝炎和34例男性肝硬化患者的HA、Ⅳ-C、PⅢNP、LN;同时采用放免法检测上述对象的雌酮(E1)、雌二醇(E2)、雌三醇(E3)。结果肝炎组以及肝硬化组的HA、PⅢNP、Ⅳ-C和LN明显高于正常组(P<0.05或P<0.01),且肝硬化组明显高于肝炎组(P<0.05或P<0.01)。肝炎组以及肝硬化组的E1、E3明显高于正常组(P<0.05或P<0.01),且肝硬化组明显高于肝炎组(P<0.05或P<0.01)。三组的E2水平逐渐增高,但是无显著性差异(P>0.05)。E1、E3浓度与HA、Ⅳ-C呈正相关,E2与两种指标均无明显相关性。结论肝纤维化患者存在不同程度的雌激素水平升高,并且雌酮、雌三醇的升高程度与肝硬化肝功能受损程度有明显关系,测定雌激素水平变化,可以作为临床判断预后、疗效的一个指标。 Objective To explore the relationship between serum levels of estrogen and hyalurnic acid, procollagen -Ⅲ, collagen - Ⅳ and layer mucigen and severity of liver dysfunction in the male patients with fibrosis of liver. Methods HA, P Ⅲ NP,Ⅳ - C, LA were measured by ELISA and E1, E2, E3 were measured by radioimmunoassay in 34 cases cirrhosis , then compared with 26 chronic hepatitis and 31 cases normal. Results In chronic hepatitis group and cirrhosis group ,the hyalurnic acid, HA, PⅢNP, Ⅳ -C and LN are significantly higer than control group( P 〈 0. 05 or P 〈 0.01 ). In chronic hepatitis group and cirrhosis group , E1 and E3 levels are significantly higer than control group. That of cirrhosis group higer than hepatitis group. No difference was found in E2 level among three groups( P 〉0. 05 ). E1 level and E3 level are correlated positively with HA, Ⅳ - C. E2 levd are not correlated with them. Conclusion Hepatocirrhosis has varying amounts of disorder in levels of estrogen in serum , depending on liver function lesion gravity , the determination of above hormone could be deserved as a standard for clinical state of illness.
作者 张华煜
出处 《中国医学创新》 CAS 2010年第35期27-29,共3页 Medical Innovation of China
关键词 肝纤维化 雌酮 雌二醇 雌三醇 Fibrosis of liver Estrone Estradiol Estriol
  • 相关文献

参考文献8

二级参考文献37

  • 1叶红军,高永生,王丽英,肖红,计秀生,潘春芝,冯雪梅.血清Ⅲ型前胶原对肝纤维化的诊断价值[J].临床肝胆病杂志,1993,9(2):90-92. 被引量:65
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3石小英 沈通良 等.肝硬化患者血清性激素测定[J].四川医学,1992,13(4):255-255.
  • 4李家敏 叶维法.肝病三联征发生机制的探讨[J].临床肝胆病杂志,1988,4(2):41-41.
  • 5蔡卫民 叶维法 等.肝纤维化血清学指标的检测.肝胆病诊断学(第1版)[M].天津:天津科技出版社,1998.190-200.
  • 6[1]Stavreus-Evers AC, Freyschuss B, Eriksson HA. Hormonal regulation of the estrogen receptor in primary cultures of hepatocytes from female rats [J]. Steroids, 1997, 62(10):647-654.
  • 7[2]Gressner AM. The cell biology of liver fibrogenesis-an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts [J]. Cell Tissue Res, 1998, 292(3):447-452.
  • 8[3]Rice-Evans C, Hochstein P. Alternation in erythrocyte membrane fluidity by phenylhdrazine induced peroxidation of lipids [J]. Biochem Biophys Res Commun, 1981,100(4):1537-1542.
  • 9[4]Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis [J]. J Hepatology,2001, 35(2): 297-306.
  • 10[1]Poynard T, Bedossea P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C .The OBSVIRC, METAVIR, CLINIVIR,and DOSVIRC groups. Lancet, 1997,349 (9055): 825-832.

共引文献78

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部